Did You Know...
...that after Parker Brothers executives turned down the game of Monopoly because it had "52 fundamental errors" (including taking too long to play), a copy of the game wound up in the home of the company president who stayed up until 1 a.m. to finish playing it? He was so impressed by the game that the next day he wrote to inventor Charles Darrow and offered to buy it!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120107367 | Site-Specific Intestinal Delivery of Adsorbents, Alone or in Combination with Degrading Molecules Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, and methods... | 05/03/2012 |
| 20120016347 | Seroma Control for Surgical Patients Apparatus and methods for significant reduction of seroma formation, seroma related complications and time until drain removal following surgery are disclosed. Talc, with and without thrombin, bleomycin, erythromycin, tetracycline, doxycycline, polidocanol alone or in c... | 01/19/2012 |
| 20120003328 | MODIFIED SODIUM-MONTMORILLONITE, PREPARATION METHOD AND USES THEREOF Provided are a modified Na-montmorillonite and a preparation method thereof, wherein the content of Na+ in the modified sodium-montmorillonite, calculated as Na2O, is not less than 2.0%. The modified Na-montmorillonite has more reasonable microstru... | 01/05/2012 |
| 20110142910 | Clotting and Healing Compositions Containing Keratin Biomaterials Disclosed are optimized keratin preparations for use in medical applications. Methods to produce optimized keratin preparations are provided for use in biomedical applications, particularly for the treatment of bleeding, and for the treatment of wounds. Also disclosed a... | 06/16/2011 |
| 20100303931 | COSMETIC COMPOSITION COMPRISING AN INULIN DERIVATIVE IN THE FORM OF AN EMULSION EXPANDED IN VOLUME A subject-matter of the present invention is a cosmetic composition expanded in volume, in the form of an oil-in-water emulsion, comprising an internal fatty phase and an external aqueous phase comprising at least one inulin modified by hydrophobic chains and at least t... | 12/02/2010 |
| 20100297191 | METHOD FOR MANUFACTURING A CLEANSING AND/OR CARE ARTICLE The invention relates to the use of a cleansing and/or care composition for impregnating a pile of absorbent supports. The care and cleansing composition has a relatively high apparent viscosity while having a rheological behavior of the sh... | 11/25/2010 |
| 20100291239 | MIXTURE OF CITRIC FLAVONOIDS TO IMPROVE RUMINAL FERMENTATION The invention refers to the use of a mixture of naringin, bitter orange extract and sepiolite to improve ruminal fermentation in ruminants.... | 11/18/2010 |
| 20100233222 | COSMETIC SKIN TREATMENT PROCESS Cosmetic treatment processes include application of cosmetic compositions to a skin surface by spraying, such compositions including at least one filler in a physiologically acceptable medium, the at least one filler giving the composition a haze index H of 40% or more ... | 09/16/2010 |
| 20100189683 | Pulsatile Dosing of Gossypol for Treatment of Disease This invention relates to pulsatile dose administration of gossypol or pharmaceutical compositions thereof for treating diseases, disorders and conditions responsive to gossypol, inhibiting the activity of anti-apoptotic Bcl-2 family proteins, inducing apoptosis in cell... | 07/29/2010 |
| 20100158825 | COSMETIC AND PERSONAL CARE PRODUCTS CONTAINING SYNTHETIC MAGNESIUM ALUMINO-SILICATE CLAYS The invention provides for cosmetic and personal care compositions comprising a synthetic magnesium aluminosilicate clay. The synthetic magnesium aluminosilicate clay is formed at ambient pressure by a series of reaction steps and a pH change from acidic pH to basic pH.... | 06/24/2010 |
| 20100098780 | FLAKY PARTICLE AND COSMETIC The present invention has an object to provide a flaky particulate material giving skin an excellent smoothness, which is free from whitening problem upon use thereof owing to its high transparency. The present invention also has another object to provide a cosmetic com... | 04/22/2010 |
| 20100003348 | USE OF CLAYS FOR TREATING COELIAC DISEASE The invention relates to the use of a clay for the preparation of a medicament for treating coeliac disease. Preferably, the clay used is of smectite type.... | 01/07/2010 |
| 20090291149 | Method for treatment of overfiltering and leaking blebs with sterile talc The present invention provides a method for treatment of overfiltering and leaking blebs in patients after glaucoma surgery comprising administering to said leaking bleb an effective amount of sterile talc, to thereby seal said leaking bleb and prevent bleb leakage.... | 11/26/2009 |
| 20090208592 | THICKENED PRODUCT AND METHOD FOR TRANSFERRING HEATED FLOWABLE COSMETIC ONTO SKIN A product and method for treating skin with a heated lotion is herein described. The product is a package with associated instructions for applying a heated cosmetic composition to skin dispensed from a heating device. The cosmetic composition includes an inorganic stru... | 08/20/2009 |
| 20090175959 | Controlled Release Solid Preparation The present invention provides a controlled release solid preparation superior in the stability of an active ingredient, which can exhibit pharmacological effects steadily and rapidly after administration, and shows a sustained pharmacological effect for a prolonged per... | 07/09/2009 |
| 20090130223 | COSMETIC PREPARATION WITH AQUAPORIN STIMULATORS AND THE USE THEREOF The development relates to cosmetic and dermatological preparations containing aquaporin stimulators, in particular glyceryl glycosides, and their use to improve the moisturizing of the skin.... | 05/21/2009 |
| 20080317830 | Compositions and Methods for the Treatment of Wounds and Scar Tissue Compositions for the treatment of wounds and/or scars are described herein. The compositions contain between 1 and up to 30% by weight, more preferably between 1 and 20%, most preferably between about 5 and 10% by weight particles, such as titanium dioxide or a similar ... | 12/25/2008 |
| 20080299226 | Hemostatic Agent Composition and Method of Delivery A hemostatic agent composition that includes a clay hemostatic agent which is inert and non-reactive relative to blood clotting proteins and platelets, yet is capable of accelerating the formation of a stable clot when applied to an actively bleeding wound.... | 12/04/2008 |
| 20080206361 | Insecticidal Compositions Suitable For Use in Preparation of Insecticidal Liquid Fertilizers Insecticidal compositions suitable for use in preparation of insecticidal liquid fertilizers comprising a pyrethroid, a hydrated aluminum-magnesium silicate, and at least one dispersant selected from the group consisting of a sucrose ester, a lignosulfonate, an alkylpol... | 08/28/2008 |
| 20080063697 | Use of Unactivated Calcium Exchanged Zeolites in Hemostatic Devices and Products It is known that activated and partially activated zeolites are effective in hemostasis. However, the use of fully hydrated, unactivated zeolites has been ignored up to this point based upon a belief that it was necessary for such zeolites to concentrate certain compone... | 03/13/2008 |
| 20080044493 | Agent For Ameliorating The Maximum Passage Time Through Digestive Tract, Agent For Ameliorating Passage Time Through Digestive Tract And Preventive For Colon Cancer The present invention provides food or preventive drugs whereby food residues retained in the digestive tract over a long period of time due to, for example, overeating even in a healthy person not suffering from constipation and having regular defecation can be dischar... | 02/21/2008 |
| 20080031973 | Means of improving hand grip An antislip agent directly applicable to the hands for a short-term negation of the effects of perspiration on grip security. The hands will also become slightly sticky for 1 to 2 minutes upon use, after which time the effect of this invention will disappear, allowing o... | 02/07/2008 |
| 20070231412 | Virus-interacting layered phyllosilicates and methods of inactivating viruses in the gastrointestinal tract Layered phyllosilicates are useful for adsorbing and/or binding to and, thereby, inactivating viruses. Accordingly, provided herein is a method of inactivating a virus in the gastrointestinal tract of a mammalian subject comprising administering to said subject a compos... | 10/04/2007 |
| 20070224293 | Virus-interacting layered phyllosilicates and methods of inactivating viruses on animate and inanimate surfaces Layered phyllosilicates are useful for adsorbing and/or binding to and, thereby, inactivating viruses. Accordingly, provided herein is a method of inhibiting transfer of a virus to a surface comprising contacting the surface with a composition comprising a layered phyll... | 09/27/2007 |
| 20070154568 | Clay Purification Method The invention relates to a method for the purification of a clay that is intended for therapeutic use. ... | 07/05/2007 |
| 20070031461 | AN ANTIMICROBIAL COMPOSITION FOR TOPICAL APPLICATION AND A METHOD THEREOF The present invention provides an antimicrobial composition for topical application, preferably for treating acne, and a method for using the composition. The composition comprises a photocatalyst mixture comprising a photocatalyst, such as titanium dioxide, and sodium ... | 02/08/2007 |
| 20060292242 | Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms The invention relates to lowering the lactate values or the ammonium values in the blood of mammals, including humans. According to the invention, ground zeolites are administered orally in the form of a consumption product or a drug. In particular, the zeolite is chose... | 12/28/2006 |
| 20060204594 | Inhibition of enzyme activity by adsorptive removal of controlling ions Methods of preparing and using natural or synthetic zeolitic compositions therapeutically, so as to alleviate, cure, or even preclude human host disease attributable to exposure to bacteria within the Bacillus anthracis group: comprising, B. anthracis, B. cere... | 09/14/2006 |
| 20060018976 | Nutritional supplement for osteoarthritis The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain Smectite, Gypsum, Quartz, Feldspar, Jarosite, Kaolinite and/or Zeolite. ... | 01/26/2006 |
| 20050129782 | Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions The use of inorganic nanoparticles to stabilize aqueous hydrogen peroxide solutions is described. The preferred nanoparticles are formed from clays. The use of nanoparticles formed from synthetic smectite clays is particularly preferred. The stabilized hydrogen peroxide... | 06/16/2005 |
| 20050123627 | Azithromycin dosage forms with reduced side effects An oral dosage form comprising azithromycin and an effective amount of an alkalizing agent. Preferably, said oral dosage form comprises an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, ... | 06/09/2005 |
| 20050038018 | Meloxicam compositions A pharmaceutical composition comprising: (a) meloxicam or a pharmaceutically acceptable salt thereof; and (b) one or more additional pharmaceutically active compounds selected from antacids, sedatives, and central nervous system stimulants, and the use of such compositi... | 02/17/2005 |
